Go Pro

Pharma-Bio Serv (PBSV) Earnings Date, Estimates & Call Transcripts

Pharma-Bio Serv logo
$0.57 0.00 (0.00%)
As of 07/2/2026

Pharma-Bio Serv Earnings Summary

Pharma-Bio Serv released Q2 2026 earnings on June 15, 2026, reporting an EPS of $0.01, which missed analysts' consensus estimates of $0.03 by $0.02. Quarterly revenue was reported to be $2.70 billion, above analyst estimates of $2.70 million. With a trailing EPS of $0.00, Pharma-Bio Serv's earnings are expected to grow 57.14% next year, from $0.07 to $0.11 per share.

Q2 2026 Earnings Resources

PBSV Upcoming Earnings

Pharma-Bio Serv's next earnings date is estimated for Monday, September 21, 2026, based on past reporting schedules.

Upcoming Q3
Earnings Date
Sep. 21Before Market OpensEstimated
Consensus EPS
(Jun. 15)
$0.03
Actual EPS
(Jun. 15)
$0.01 Missed By -$0.02
Actual Revenue
(Jun. 15)
$2.70B
Get Pharma-Bio Serv Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pharma-Bio Serv and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

PBSV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PBSV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Pharma-Bio Serv Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261$0.02$0.02$0.02
Q2 20261$0.03$0.03$0.03
Q3 20261$0.03$0.03$0.03
Q4 20261$0.03$0.03$0.03
FY 2026 4 $0.11 $0.11 $0.11
Q1 20271$0.02$0.02$0.02
Q2 20271$0.02$0.02$0.02
Q3 20271$0.03$0.03$0.03
Q4 20271$0.04$0.04$0.04

Pharma-Bio Serv Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
9/21/2026
(Estimated)
--------
6/15/2026Q2 2026$0.03$0.01 -$0.02$0.01$2.70M$2.70B
3/17/2026Q1 2026$0.02$1.43+$1.41-$2.70M$2.30M
9/15/2025Q3 2025$0.03-$0.01 -$0.04-$0.01$3.00M$1.96M
3/17/2025Q1 2025$0.02$0.3718+$0.3518-$2.70M$2.47M
9/16/2024Q3 2024$0.03-$0.01 -$0.04-$0.01$3.50M$2.42M

Data powered by Fiscal.ai.

Pharma-Bio Serv Earnings - Frequently Asked Questions

Pharma-Bio Serv has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, September 21st, 2026 based off last year's report dates. Learn more on PBSV's earnings history.

In the previous quarter, Pharma-Bio Serv (OTCMKTS:PBSV) missed the analysts' consensus estimate of $0.03 by $0.02 with a reported earnings per share (EPS) of $0.01. Learn more on analysts' earnings estimate vs. PBSV's actual earnings.

Pharma-Bio Serv (OTCMKTS:PBSV) has a recorded annual revenue of $9 million.

Pharma-Bio Serv (OTCMKTS:PBSV) has a recorded net income of -$100,000.00. PBSV has generated $0.00 earnings per share over the last four quarters.

Pharma-Bio Serv's earnings are expected to grow from $0.07 per share to $0.11 per share in the next year, which is a 57.14% increase.


This page (OTCMKTS:PBSV) was last updated on 7/6/2026 by MarketBeat.com Staff.
From Our Partners